| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |